Overview
A technical help webinar was held for potential candidates of the next Discover of Funding Alternative (NOFO): Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Clinical High Risk for Psychosis Clinical Trial Network (U01 Clinical Trial Required) . Nationwide Institute of Psychological Well being workers answered questions associated to this NOFO.
The aim of this NOFO is to assist one scientific trial community to guage organic, digital, cognitive, and scientific end result measures in people at scientific excessive danger (CHR) for psychosis in Proof of Precept (PoP) trial(s) utilizing a pharmacological intervention. Distinctive drug improvement instruments developed via AMP® SCZ initiative shall be evaluated within the PoP trial(s). The compound(s) chosen for testing by the AMP SCZ Steering Committee will have an effect on a pathophysiologically related mechanism and have the potential to provide a detectable sign on organic, digital, cognitive, or scientific end result measures inside a 12-16 week interval of examine.
Recording
Learn the transcript.
Sponsored by
Division of Translational Analysis
Contact
Jonathan Sabbagh, Ph.D.
[email protected]
